295 related articles for article (PubMed ID: 32592539)
21. Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.
Mo J; Liu J; Wu S; LÜ A; Xiao L; Chen D; Zhou Y; Liang L; Liu X; Zhao J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):536-541. PubMed ID: 32879103
[TBL] [Abstract][Full Text] [Related]
22. Understanding factors influencing the length of hospital stay among non-severe COVID-19 patients: A retrospective cohort study in a Fangcang shelter hospital.
Wu S; Xue L; Legido-Quigley H; Khan M; Wu H; Peng X; Li X; Li P
PLoS One; 2020; 15(10):e0240959. PubMed ID: 33085709
[TBL] [Abstract][Full Text] [Related]
23. Changes in blood coagulation in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis.
Xiong M; Liang X; Wei YD
Br J Haematol; 2020 Jun; 189(6):1050-1052. PubMed ID: 32304581
[No Abstract] [Full Text] [Related]
24. COVID-19 and coagulative axis: review of emerging aspects in a novel disease.
Boccia M; Aronne L; Celia B; Mazzeo G; Ceparano M; D'Agnano V; Parrella R; Valente T; Bianco A; Perrotta F
Monaldi Arch Chest Dis; 2020 May; 90(2):. PubMed ID: 32425013
[TBL] [Abstract][Full Text] [Related]
25. Coronavirus Disease 2019: Hematological Anomalies and Antithrombotic Therapy.
Ornelas-Ricardo D; Jaloma-Cruz AR
Tohoku J Exp Med; 2020 Aug; 251(4):327-336. PubMed ID: 32788506
[TBL] [Abstract][Full Text] [Related]
26. Clinical characteristics of chronic liver disease with coronavirus disease 2019 (COVID-19): a cohort study in Wuhan, China.
Li C; Chen Q; Wang J; Lin H; Lin Y; Lin J; Peng F; Chen J; Yang Z
Aging (Albany NY); 2020 Aug; 12(16):15938-15945. PubMed ID: 32855361
[TBL] [Abstract][Full Text] [Related]
27. A Retrospective Study of the C-Reactive Protein to Lymphocyte Ratio and Disease Severity in 108 Patients with Early COVID-19 Pneumonia from January to March 2020 in Wuhan, China.
Yang M; Chen X; Xu Y
Med Sci Monit; 2020 Sep; 26():e926393. PubMed ID: 32914767
[TBL] [Abstract][Full Text] [Related]
28. Analysis of coagulation parameters in patients with COVID-19 in Shanghai, China.
Zou Y; Guo H; Zhang Y; Zhang Z; Liu Y; Wang J; Lu H; Qian Z
Biosci Trends; 2020 Sep; 14(4):285-289. PubMed ID: 32350161
[TBL] [Abstract][Full Text] [Related]
29. [Dealing with COVID-19-associated coagulopathy].
Klok FA; den Exter PL; Huisman MV; Eikenboom J
Ned Tijdschr Geneeskd; 2020 Apr; 164():. PubMed ID: 32395964
[TBL] [Abstract][Full Text] [Related]
30. Abnormal liver-related biomarkers in COVID-19 patients and the role of prealbumin.
Li T; Guo Y; Zhuang X; Huang L; Zhang X; Wei F; Yang B
Saudi J Gastroenterol; 2020; 26(5):272-278. PubMed ID: 32769260
[TBL] [Abstract][Full Text] [Related]
31. Spectrum of Neurological Manifestations in Covid-19: A Review.
Garg RK
Neurol India; 2020; 68(3):560-572. PubMed ID: 32643664
[TBL] [Abstract][Full Text] [Related]
32. SARS-CoV-2 and Stroke in a New York Healthcare System.
Yaghi S; Ishida K; Torres J; Mac Grory B; Raz E; Humbert K; Henninger N; Trivedi T; Lillemoe K; Alam S; Sanger M; Kim S; Scher E; Dehkharghani S; Wachs M; Tanweer O; Volpicelli F; Bosworth B; Lord A; Frontera J
Stroke; 2020 Jul; 51(7):2002-2011. PubMed ID: 32432996
[TBL] [Abstract][Full Text] [Related]
33. [Research progress of coagulation dysfunction in coronavirus disease 2019].
Zhong S; Wu F; Peng N; Xie Q; Song J; Li W
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Sep; 32(9):1135-1138. PubMed ID: 33081906
[TBL] [Abstract][Full Text] [Related]
34. Current Overview on Hypercoagulability in COVID-19.
Singhania N; Bansal S; Nimmatoori DP; Ejaz AA; McCullough PA; Singhania G
Am J Cardiovasc Drugs; 2020 Oct; 20(5):393-403. PubMed ID: 32748336
[TBL] [Abstract][Full Text] [Related]
35. Coagulation Panel in Patients with SARS-CoV2 Infection (COVID-19).
Guevara-Noriega KA; Lucar-Lopez GA; Nuñez G; Rivera-Aguasvivas L; Chauhan I
Ann Clin Lab Sci; 2020 May; 50(3):295-298. PubMed ID: 32581015
[TBL] [Abstract][Full Text] [Related]
36. Prognosis of COVID-19: Changes in laboratory parameters.
Lagadinou M; Salomou EE; Zareifopoulos N; Marangos M; Gogos C; Velissaris D
Infez Med; 2020 Jun; 28(suppl 1):89-95. PubMed ID: 32532944
[TBL] [Abstract][Full Text] [Related]
37. Systemic Inflammatory Response Syndrome Is a Major Contributor to COVID-19-Associated Coagulopathy: Insights From a Prospective, Single-Center Cohort Study.
Masi P; Hékimian G; Lejeune M; Chommeloux J; Desnos C; Pineton De Chambrun M; Martin-Toutain I; Nieszkowska A; Lebreton G; Bréchot N; Schmidt M; Edouard Luyt C; Combes A; Frere C
Circulation; 2020 Aug; 142(6):611-614. PubMed ID: 32776849
[No Abstract] [Full Text] [Related]
38. Infection with SARS-CoV-2 causes abnormal laboratory results of multiple organs in patients.
Yang AP; Li HM; Tao WQ; Yang XJ; Wang M; Yang WJ; Liu JP
Aging (Albany NY); 2020 Jun; 12(11):10059-10069. PubMed ID: 32484453
[TBL] [Abstract][Full Text] [Related]
39. Coagulopathy in COVID-19: Manifestations and management.
Mucha SR; Dugar S; McCrae K; Joseph D; Bartholomew J; Sacha GL; Militello M
Cleve Clin J Med; 2020 Jul; 87(8):461-468. PubMed ID: 32409435
[TBL] [Abstract][Full Text] [Related]
40. Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study.
Lian N; Xie H; Lin S; Huang J; Zhao J; Lin Q
Clin Microbiol Infect; 2020 Jul; 26(7):917-921. PubMed ID: 32344167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
